Literature DB >> 3055969

Immunoglobulin-antiimmunoglobulin interactions and immune complexes in IgA nephropathy.

S Jackson1.   

Abstract

IgA nephropathy (IgAN) is characterized by mesangial co-deposition of IgA and C3. Elevated levels of circulating immune complexes containing these components in significant numbers of patients have been found in several studies; IgAN is therefore assumed by many investigators to be an immune complex-mediated disease. Our studies have shown that IgG is often co-complexed with IgA within circulating immune complexes, and we have begun to examine the potential mechanisms for these observations. In this regard, elevated levels of IgA rheumatoid factor and of IgG anti-IgA antibodies were found in some patients. Nevertheless, we were unable to correlate levels of circulating immune complexes with any clinical index of disease. Furthermore, many individuals with the acquired immune deficiency syndrome (AIDS) also have elevated levels of circulating immune complexes containing IgG and IgA, IgA rheumatoid factor, and IgG anti-IgA antibodies, although these patients apparently do not have mesangial IgA deposits. Therefore, the role of circulating IgA-containing immune complexes in the pathogenesis of IgAN requires further evaluation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055969     DOI: 10.1016/s0272-6386(88)80039-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Authors:  M Tomana; J Novak; B A Julian; K Matousovic; K Konecny; J Mestecky
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 3.  Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.

Authors:  Taylor Person; R Glenn King; Dana V Rizk; Jan Novak; Todd J Green; Colin Reily
Journal:  J Interferon Cytokine Res       Date:  2022-07-06       Impact factor: 3.657

4.  Anti-immunoglobulin antibodies in children with Schönlein-Henoch syndrome. Absence of serum anti-IgA antibodies.

Authors:  A Blanco Quirós; C Blanco; J Alvarez; P Solis; F Conde; S Gomez
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

Review 5.  IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Milan Tomana; Jiri Mestecky
Journal:  Semin Nephrol       Date:  2008-01       Impact factor: 5.299

Review 6.  Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Authors:  J Mestecky; M Tomana; Z Moldoveanu; B A Julian; H Suzuki; K Matousovic; M B Renfrow; L Novak; R J Wyatt; J Novak
Journal:  Kidney Blood Press Res       Date:  2008-01-08       Impact factor: 2.687

7.  Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.

Authors:  Yusuke Suzuki; Keiichi Matsuzaki; Hitoshi Suzuki; Keiko Okazaki; Hiroyuki Yanagawa; Norio Ieiri; Mitsuhiro Sato; Toshinobu Sato; Yoshio Taguma; Joe Matsuoka; Satoshi Horikoshi; Jan Novak; Osamu Hotta; Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2014-01-30       Impact factor: 2.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.